 |
| Insulin Market |
According to a new market
report published by Transparency Market Research "Insulin Market - Global
and China Scenario, Trends, Industry Analysis, Size, Share and Forecast, 2011 -
2018" the global insulin market was worth USD 12,476.3 million in 2011 and
is expected to reach USD 32,346.7 million in 2018, growing at a CAGR of 12%
from 2011 to 2018. In the global market, China is expected to increase its
share in the global insulin market to 10.2% by 2018.
The global insulin market
is driven by rise in diabetic population worldwide. The world diabetes
population was estimated at 366 million in the year 2011, and is expected to
reach 552 million in 2030. It is estimated that diabetes accounts for 4.6
million deaths, with cases of people dying due to lack of insulin and not even
being diagnosed.
This however, presents a
huge supply demand deficit for insulin, with high growth potential in
developing markets. The factors contributing to the insulin market growth also
includes increase in global expenditure on healthcare, strong distribution
network, and high scope in developing economies such as China and India.
Browse the full Insulin Market Report at http://www.transparencymarketresearch.com/insulin-market.html
It is estimated that
worldwide, by year 2030, one in ten people will suffer from diabetes, giving
rise to huge demand for insulin. China, being the most populous nation in the
world, accounts for the largest share of the global diabetic population and
eventually turns out as the most lucrative market for insulin manufacturers.
Get Free Sample Report at http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=259
The China insulin market
is projected to grow at a CAGR twice that of the global insulin market. It was
estimated at USD 723.8 million in 2011, and is projected to reach USD 3,299.1
million in the year 2018, growing at a CAGR of 24.6%. Currently, China accounts
for 6.1% of the global insulin market in terms of volume, which was estimated
at 22.4 tMU in 2011. The global insulin market by volume is projected to grow
at a CAGR of 7.9% from 2012 - 2018.
Browse
Blog http://tmrresearch.wordpress.com/
The global insulin market
has continuously witnessed new advanced product types being introduced in the
market by insulin manufacturers. The recent product type is modern insulin,
which is a genetically engineered version of human insulin, and has been
selectively modified to counter the issues associated with human insulin.
Currently, modern insulin accounts for more than 76% of the global insulin
market.
To meet the rising demand,
global insulin manufacturers are not only augmenting existing production
facilities, but also expanding their global presence to meet the supply demand
gap. Leading insulin manufacturers are now focusing on reinforcing their market
leadership in China. It includes key global and China insulin market players
such as Novo Nordisk, Sanofi-Aventis, and Eli-Lilly. Together they account for
more than 90% of the global insulin market share.
Browse
all Pharmaceutical Research Report at http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html
This research is specially
designed to estimate and analyze the demand and performance of the global and
China insulin market in the current market scenario. This research provides
in-depth analysis of insulin manufacturers, product sales, trend analysis by
segments, and demand by geography. The report covers all the major product
segments of the global and China insulin market and provides in-depth analysis,
historical data and statistically refined forecast for the segments covered.
0 comments:
Post a Comment